ArticleOncology letters2024

First‑line endocrine therapy for hormone receptor positive and HER‑2 negative metastatic breast cancer: A Bayesian network meta‑analysis.

Yi-Cheng Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.